Cargando…

Prognosis of recurrence after complete resection in early-stage lung adenocarcinoma based on molecular alterations: a systematic review and meta-analysis

Molecular biomarkers have the potential to predict the recurrence risk of early-stage lung adenocarcinoma (LUAD) after complete resection, but the study results are controversial. We aimed to clarify the association of molecular alterations with disease-free survival (DFS) and recurrence-free surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chu, Jing, Zhongying, Liu, Wei, Ma, Zihuan, Liu, Siyao, Fang, Yueyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618289/ https://www.ncbi.nlm.nih.gov/pubmed/37907475 http://dx.doi.org/10.1038/s41598-023-42851-2

Ejemplares similares

Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer
por: Choi, Pil Jo, et al.
Publicado: (2013)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
por: Zhao, Zihuan, et al.
Publicado: (2020)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Identification of molecular signatures associated with early relapse after complete resection of lung adenocarcinomas
por: Pasternack, Helen, et al.
Publicado: (2021)

Optimal margins for early stage peripheral lung adenocarcinoma resection
por: Yin, Pan, et al.
Publicado: (2021)

Prognosis of early stage pulmonary mucinous adenocarcinoma with different treatments
por: Liu, Jinyuan, et al.
Publicado: (2020)

Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
por: Xu, Fei, et al.
Publicado: (2022)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma
por: Choi, Yeonseok, et al.
Publicado: (2020)

Prognosis of recurrent non-small cell lung cancer following complete resection
por: SASAKI, HIDEFUMI, et al.
Publicado: (2014)

Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma
por: Li, Pupu, et al.
Publicado: (2019)

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
por: Hu, Chunhong, et al.
Publicado: (2022)

Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
por: Yotsukura, Masaya, et al.
Publicado: (2020)

The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?
por: Ji, Ying, et al.
Publicado: (2021)

Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma
por: Im, Dong Jin, et al.
Publicado: (2021)

Tumor‐associated N1 and N2 neutrophils predict prognosis in patients with resected pancreatic ductal adenocarcinoma: A preliminary study
por: Yin, Hanlin, et al.
Publicado: (2022)

Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
por: Li, Xiaojie, et al.
Publicado: (2020)

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Prognosis of Early Stage Cervical Cancer According to Patterns of Recurrence
por: Chen, Yuanyuan, et al.
Publicado: (2021)

Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients
por: Chen, Jun, et al.
Publicado: (2017)

Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection
por: Yoshida, Chihiro, et al.
Publicado: (2022)

Left Lung Torsion: Complication of Lobar Resection for an Early Stage Lung Adenocarcinoma
por: Mansour, Wissam, et al.
Publicado: (2016)

Early recurrence detected by (18)F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2020)

Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
por: Li, Shengnan, et al.
Publicado: (2022)

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)

Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma
por: Saji, Hisashi, et al.
Publicado: (2017)

Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma
por: Orsini, Arianna, et al.
Publicado: (2023)

Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns
por: Wangjam, Tamna, et al.
Publicado: (2015)

Long-Term Recurrence of Completely Resected NSCLC
por: Masago, Katsuhiro, et al.
Publicado: (2020)

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection
por: Wu, Yu-Chung, et al.
Publicado: (2017)

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC
por: Lee, Jay M., et al.
Publicado: (2023)

THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA
por: EYFF, Tatiana Falcão, et al.
Publicado: (2018)

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
por: Xu, Ying, et al.
Publicado: (2023)

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)

Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma
por: Wang, Xintao, et al.
Publicado: (2023)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection
por: He, Chaobin, et al.
Publicado: (2021)

An In Silico Analysis Reveals an EMT-Associated Gene Signature for Predicting Recurrence of Early-Stage Lung Adenocarcinoma
por: Han, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2931ud6o2fqrgo80crdvlohgvm